The NASDAQ opened a full 3% down this morning. Absolute panic on Wall Street. But this is not a collapse. The 2026 market rotation has begun, and it's creating one of the biggest opportunities of the year.
Not everything is going down. In fact, a couple of areas of the market are surging. Money is rotating fast out of overextended tech names and into fresh leadership sectors. If you can track where that capital is flowing, you can position for massive upside while everyone else panics.
Is the 2026 Market Rotation a Collapse or an Opportunity?
Bottom Line: The 2026 market rotation is a capital flow story, not a crash. Semiconductors priced in years of good news during a historic run, and that money is now moving into early-stage biotech and quantum computing names like IOVA and LAES. The opportunity is in reading the divergence between indexes, not reacting to the red on the NASDAQ.
The NASDAQ is down 2.5%. But the S&P is only off 1%. The Russell is down a quarter percent. And the Dow Jones is actually up.
That price action tells you one thing: rotation. Money is not leaving the market. It is simply moving to areas with better valuations and fresh growth drivers.
Why Are Semiconductor Stocks Selling Off in 2026?
The sectors that performed best over the last several periods have a clear winner. Semiconductors have massively outperformed the market across every single timeframe.
This pace is simply not sustainable. This is not a single stock. There's an entire industry up 108% in six months and 168% in twelve months. A lot of these stocks have gotten very extended and have already priced in all the good news.
Most of the morning selloff came directly from this sector. The money is cashing out of semiconductors and looking for a new home.
Biotech Is Ripping Higher
While the broader market gets hammered, the biotech sector is doing the exact opposite. It's up. Big.
That is the definition of rotation. Money is shifting directly into biotech. The assumption is that AI development and research software are powering new advancements in this space. The sector had a big run in late 2025, moving from 120 to 180, before planing out. It consolidated in the lows for six to seven months and is now breaking out to new highs.
The Broad Sector Play
The simplest way in: buy IBB. It's an ETF that tracks the entire biotechnology sector.
The Aggressive Play
For more firepower, there's BIB, the Ultra NASDAQ Biotechnology ETF. It's 2:1 leveraged. That sounds excessive, but you're doing it on an entire basket of hundreds of stocks. It's making new all-time highs right now. You could buy it here and risk about 8% with a stop loss at the 50-day moving average.
Stock #1: IOVA
A midcap biotech with real volatility and a clean setup
After running through a lot of biotech stocks, some are setting up beautifully but lack the volatility needed for big profits.
Biogen (BIIB), for example, shows a classic shallowing compression pattern as supply gets sucked out of the stock. But it's a $30 billion company with an average daily range of just 2.8%. That's similar to Walmart or 3M. Even if you nail the trade, you might only make 15% to 20%.
Iovance Biotherapeutics (IOVA) moves a lot more. It's a $2 billion midcap with an average daily range of 8.77%. The retracements in this stock go from 43% down to about 21%, then 24% to 20%, with a final shallowing of about 11%. That's consolidation. That's absorption. The supply is being sucked out of the stock.
And today, in the middle of a broad market selloff, IOVA is ripping higher and breaking out of a two-week consolidation base.
Get an entire year of live weekly mentoring sessions, my newsletter, indicators, bonus reports, tons more. Click the link and I'll see you in the next live session.
Join my Black Ops Trading ClubWhy Is Quantum Computing Attracting Rotation Money Right Now?
There's another massive shift happening right now, and it's coming off a big trigger. President Trump recently signed two executive orders, both focused on quantum computing.
This pattern has played out through the entire administration. They find an area where the U.S. is vulnerable, where we may not control supply, or where another country has the upper hand. Rare earths. Semiconductors. They step in with some combination of equity, funding, or executive orders designed to protect and enhance these industries.
According to a summary from the Kobeissi Letter on X, the two executive orders mandate the following:
- Federal agencies must work with the private sector to deploy a quantum computer powerful enough to conduct scientific research by 2028. That's only 17 months away.
- Government security experts must prepare quantum systems that can evade standard encryption more quickly than previously anticipated.
Stock #2: LAES
Quantum-resistant security chips for a world that desperately needs them
What nobody thinks about is that the same machine capable of curing diseases and cracking impossible math problems will also break the encryption that protects your bank accounts, your crypto wallets, the government's secrets. A powerful enough quantum computer can crack any code and hack any account.
Criminals already know this. Many are stealing encrypted data today, simply waiting for a quantum computer powerful enough to crack it open.
The entire world is going to have to rip out its old security chips and replace them with quantum-resistant ones. SEALSQ Corp (LAES) makes exactly that. They produce quantum-resistant security chips. They make the shield.
This stock is a massive mover. In late 2025, it ran 230% in just over a month before getting murdered. Now it has begun to shallow and consolidate, forming a rounded bottom. Buyers are stepping into the stock with a series of higher highs and higher lows.
Previous Picks: Quick Updates
AL
This stock was picked up in May. It has doubled since the entry. If you're up big on this position, consider taking partial profits.
Outlook Therapeutics (OTLK)
This was a buy 12 days ago around $0.80. The play was a high tight flag pattern ahead of an FDA second look. The stock is now at $1.80. That's a 130% to 140% gain in less than two weeks.
The near-term target is the $1.80 to $2.00 range, right where it's hitting now. If you bought this and doubled your money, it may be a good time to take some partial profits.
Follow the Money in This 2026 Market Rotation
The 2026 market rotation is not a reason to panic. It's a massive opportunity if you know where to look. Capital is draining from overextended semiconductor stocks and flowing directly into emerging leadership sectors like biotechnology and quantum computing.
By tracking this rotation, you can position yourself in stocks like IOVA and LAES before the broader market catches on. Don't let the red on the NASDAQ scare you out of the market. Follow the money, manage your risk, and focus on the sectors breaking out to new highs.
Get an entire year of live weekly mentoring sessions, my newsletter, indicators, bonus reports, tons more. Click the link and I'll see you in the next live session.
Key Takeaways
- The NASDAQ dropped 2.5% while the Dow Jones was actually up on the same session, confirming this is a rotation event, not a broad market collapse.
- Semiconductors are the sector being sold: the industry is up 168% over the past 12 months and 108% over six months, a pace that has historically preceded sharp mean-reversion.
- IOVA (Iovis Oncology) is the first stock call, positioned as a biotech beneficiary of the capital flowing out of overextended tech names.
- LAES is the second stock call, representing the quantum computing angle identified as an emerging leadership sector in this rotation.
- The S&P fell only 1% and the Russell barely 0.25% on the same day the NASDAQ dropped 2.5%, a divergence that signals where institutional money is and is not moving.
DISCLAIMER: Traders Agency does not offer financial advice. The information provided is for educational purposes only and should not be considered financial advice. Traders Agency is not responsible for any financial losses or consequences resulting from the use of the information provided. Trading carries inherent risks and may not be suitable for all individuals. You are advised to conduct your own research and seek personalized advice before making any investment decisions, recognizing the potential risks and rewards involved.
See more from Traders Agency on Google
Make us a preferred source and our market analysis will appear more prominently in your Google Search, Top Stories, and AI results.
Add to Preferred Sources